Back
PagerDuty Vs. Blueprint Medicines Industry Stock Comparison
Sell
33
PD
PagerDuty
Last Price:
$14.65
Seasonality Move:
-10.28%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Sell
33
PagerDuty (PD)
is a Sell
Is PagerDuty a Buy, Sell or Hold?
-
PD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
PD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.04 | Buy |
| Relative Strength Index (14 RSI): | 42.24 | Sell |
| Chaikin Money Flow: | -674183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.34 - 15.6) | Sell |
| Bollinger Bands (100): | (14.69 - 17.51) | Sell |
BPMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.49 | Buy |
| Relative Strength Index (14 RSI): | 76.66 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.07 - 129.15) | Buy |
| Bollinger Bands (100): | (85.79 - 122.45) | Buy |
PD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.87 | Sell |
| 20-day SMA: | 15.12 | Sell |
| 50-day SMA: | 15.41 | Sell |
| 200-day SMA: | 17.53 | Sell |
| 8-day EMA: | 13.61 | Buy |
| 20-day EMA: | 9.46 | Buy |
| 50-day EMA: | 4.96 | Buy |
| 200-day EMA: | 1.44 | Buy |
BPMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 129.38 | Buy |
| 20-day SMA: | 128.73 | Buy |
| 50-day SMA: | 119.37 | Buy |
| 200-day SMA: | 99.85 | Buy |
| 8-day EMA: | 129.26 | Buy |
| 20-day EMA: | 127.9 | Buy |
| 50-day EMA: | 120.09 | Buy |
| 200-day EMA: | 103.72 | Buy |
PagerDuty Earnings Growth & PD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.07 per share, an increase this year of $0.07 per share, and an increase next year of $0.18 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
PagerDuty Technical Analysis
| Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Blueprint Medicines Technical Analysis
| Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||